HomeCompareMAINX vs JNJ

MAINX vs JNJ: Dividend Comparison 2026

MAINX yields 21.74% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MAINX wins by $61.2K in total portfolio value
10 years
MAINX
MAINX
● Live price
21.74%
Share price
$9.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$81.2K
Annual income
$8,079.95
Full MAINX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MAINX vs JNJ

📍 MAINX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMAINXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MAINX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MAINX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MAINX
Annual income on $10K today (after 15% tax)
$1,847.83/yr
After 10yr DRIP, annual income (after tax)
$6,867.96/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, MAINX beats the other by $6,164.34/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MAINX + JNJ for your $10,000?

MAINX: 50%JNJ: 50%
100% JNJ50/50100% MAINX
Portfolio after 10yr
$50.6K
Annual income
$4,453.87/yr
Blended yield
8.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MAINX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MAINX buys
0
JNJ buys
0
No recent congressional trades found for MAINX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMAINXJNJ
Forward yield21.74%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$81.2K$20.0K
Annual income after 10y$8,079.95$827.78
Total dividends collected$48.1K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MAINX vs JNJ ($10,000, DRIP)

YearMAINX PortfolioMAINX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,874$2,173.91$10,676$355.77+$2.2KMAINX
2$16,391$2,615.59$11,407$389.39+$5.0KMAINX
3$20,650$3,112.23$12,198$426.53+$8.5KMAINX
4$25,760$3,664.51$13,056$467.62+$12.7KMAINX
5$31,836$4,272.26$13,987$513.12+$17.8KMAINX
6$38,999$4,934.45$14,998$563.56+$24.0KMAINX
7$47,378$5,649.24$16,098$619.52+$31.3KMAINX
8$57,108$6,414.03$17,295$681.69+$39.8KMAINX
9$68,331$7,225.56$18,599$750.82+$49.7KMAINX
10$81,195$8,079.95$20,022$827.78+$61.2KMAINX

MAINX vs JNJ: Complete Analysis 2026

MAINXStock

Under normal market conditions, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in debt and debt-related instruments issued by governments, quasi-governmental entities, supra-national institutions, and companies in Asia. It is non-diversified.

Full MAINX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MAINX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MAINX vs SCHDMAINX vs JEPIMAINX vs OMAINX vs KOMAINX vs MAINMAINX vs ABBVMAINX vs MRKMAINX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.